SOX4 Rabbit Polyclonal Antibody
To Order us: [email protected]
SOX4 Rabbit pAb |
|||
| A10717-100ul | Abclonal | 100 ul | EUR 369.6 |
SOX4 Rabbit pAb |
|||
| A10717-200ul | Abclonal | 200 ul | EUR 550.8 |
SOX4 Rabbit pAb |
|||
| A10717-20ul | Abclonal | 20 ul | EUR 219.6 |
SOX4 Rabbit pAb |
|||
| A10717-50ul | Abclonal | 50 ul | EUR 267.6 |
Polyclonal SOX4 Antibody (Internal) |
|||
| APR13472G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX4 (Internal). This antibody is tested and proven to work in the following applications: |
|||
SOX4 antibody |
|||
| 70R-11666 | Fitzgerald | 100 ug | EUR 603.6 |
|
Description: Rabbit polyclonal SOX4 antibody |
|||
SOX4 Antibody |
|||
| 43701-100ul | SAB | 100ul | EUR 302.4 |
SOX4 antibody |
|||
| 20R-1483 | Fitzgerald | 100 ug | EUR 846 |
|
Description: Rabbit polyclonal SOX4 antibody |
|||
SOX4 antibody |
|||
| 10R-1607 | Fitzgerald | 50 ug | EUR 290.4 |
|
Description: Mouse monoclonal SOX4 antibody |
|||
SOX4 Antibody |
|||
| ABD2610 | Lifescience Market | 100 ug | EUR 525.6 |
SOX4 Antibody |
|||
| 8123-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate (1,2). It may act as a transcriptional regulator after forming a protein complex with other proteins, such as syndecan binding protein (syntenin) (3). SOX4 contains one HMG box DNA-binding domain and may function in the apoptosis pathway leading to cell death. It has also been suggested to play a role in tumorigenesis and may mediate downstream effects of parathyroid hormone (PTH) and PTH-related protein (PTHrP) in bone development (4,5). |
|||
SOX4 Antibody |
|||
| 8123-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate (1,2). It may act as a transcriptional regulator after forming a protein complex with other proteins, such as syndecan binding protein (syntenin) (3). SOX4 contains one HMG box DNA-binding domain and may function in the apoptosis pathway leading to cell death. It has also been suggested to play a role in tumorigenesis and may mediate downstream effects of parathyroid hormone (PTH) and PTH-related protein (PTHrP) in bone development (4,5). |
|||
SOX4 antibody |
|||
| 70R-7975 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal SOX4 antibody |
|||
SOX4 antibody |
|||
| 70R-8248 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal SOX4 antibody |
|||
SOX4 Antibody |
|||
| DF2610 | Affbiotech | 200ul | EUR 420 |
SOX4 Antibody |
|||
| 1-CSB-PA022431LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SOX4. Recognizes SOX4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
|||
SOX4 Antibody |
|||
| R32196 | NSJ Bioreagents | 100 ug | EUR 419 |
SOX4 Antibody |
|||
| F47903-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
SOX4 Antibody |
|||
| F47903-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
SOX4 Antibody |
|||
| F47904-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
SOX4 Antibody |
|||
| F47904-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
SOX4 Antibody |
|||
| V3874-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors with a critical role in embryonic development and in cell-fate determination during organogenesis of the heart, pancreas, brain, and in B and T lymphocyte differentiation. SOX4 gene expression is upregulated in many cancer types, and increased SOX4 activity contributes to cellular transformation, cell survival, and metastasis. Gene expression profiling has uncovered SOX4 with upregulated activity during TGF-β-induced epithelial-mesenchymal transition (EMT) in normal and cancerous breast epithelial cells. SOX4 is indispensable for EMT and cell survival in vitro and for primary tumor growth and metastasis in vivo. SOX4 is identified as a master regulator of EMT by governing the expression of the epigenetic modifier Ezh2. |
|||
SOX4 Antibody |
|||
| V3874-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors with a critical role in embryonic development and in cell-fate determination during organogenesis of the heart, pancreas, brain, and in B and T lymphocyte differentiation. SOX4 gene expression is upregulated in many cancer types, and increased SOX4 activity contributes to cellular transformation, cell survival, and metastasis. Gene expression profiling has uncovered SOX4 with upregulated activity during TGF-β-induced epithelial-mesenchymal transition (EMT) in normal and cancerous breast epithelial cells. SOX4 is indispensable for EMT and cell survival in vitro and for primary tumor growth and metastasis in vivo. SOX4 is identified as a master regulator of EMT by governing the expression of the epigenetic modifier Ezh2. |
|||
SOX4 Antibody |
|||
| V3874SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors with a critical role in embryonic development and in cell-fate determination during organogenesis of the heart, pancreas, brain, and in B and T lymphocyte differentiation. SOX4 gene expression is upregulated in many cancer types, and increased SOX4 activity contributes to cellular transformation, cell survival, and metastasis. Gene expression profiling has uncovered SOX4 with upregulated activity during TGF-β-induced epithelial-mesenchymal transition (EMT) in normal and cancerous breast epithelial cells. SOX4 is indispensable for EMT and cell survival in vitro and for primary tumor growth and metastasis in vivo. SOX4 is identified as a master regulator of EMT by governing the expression of the epigenetic modifier Ezh2. |
|||
SOX4 Antibody |
|||
| 3168-100 | Biovision | each | EUR 483.6 |
Polyclonal SOX4 Antibody (N-Terminus) |
|||
| APR13474G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX4 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal SOX4 Antibody (N-term) |
|||
| APR14074G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX4 (N-term). This antibody is tested and proven to work in the following applications: |
|||
SOX4 Conjugated Antibody |
|||
| C43701 | SAB | 100ul | EUR 476.4 |
Anti-SOX4 Antibody |
|||
| PB9618 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-SOX4 antibody |
|||
| STJ118024 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-SOX4 antibody |
|||
| STJ191938 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Unconjugated Rabbit polyclonal to SOX4 |
|||
Anti-SOX4 Antibody |
|||
| A1664-100 | Biovision | each | EUR 574.8 |
SOX4 siRNA |
|||
| 20-abx934733 | Abbexa |
|
|
SOX4 siRNA |
|||
| 20-abx934734 | Abbexa |
|
|
SOX4 Peptide |
|||
| 8123P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: SOX4 Peptide |
|||
anti-SOX4 |
|||
| YF-PA24751 | Abfrontier | 50 ul | EUR 400.8 |
|
Description: Mouse polyclonal to SOX4 |
|||
SOX4 Antibody, HRP conjugated |
|||
| 1-CSB-PA022431LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SOX4. Recognizes SOX4 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
SOX4 Antibody, FITC conjugated |
|||
| 1-CSB-PA022431LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SOX4. Recognizes SOX4 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
SOX4 Antibody, Biotin conjugated |
|||
| 1-CSB-PA022431LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SOX4. Recognizes SOX4 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC042540-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF405S conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC042540-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF405S conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCA2540-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), APC conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCAP2540-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCAP2540-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCH2540-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCH2540-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNCP2540-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), PerCP conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC942540-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF594 conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC942540-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF594 conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC812540-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF680R conjugate, Concentration: 0.1mg/mL |
|||
SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540) Antibody |
|||
| BNC812540-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against SOX4 (Master Regulator of Epithelial-Mesenchymal Transition) (SOX4/2540), CF680R conjugate, Concentration: 0.1mg/mL |
|||